Insulet (PODD) Stock Price
$272.7 0.5%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Insulet, AI stock picks, stock alerts and much more.
PODD AI Stock Analysis
AI stock analysis for PODD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Insulet (PODD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Insulet (PODD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Insulet (PODD), currently trading at $272.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PODD
-
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
-
Symbol
PODD
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
19.2B
Similar Stocks
 |
Align Technology ALGN |
$170 0.2% |
5 |
 |
iRhythm Technologies IRTC |
$106.6 0.7% |
5 |
 |
Dexcom DXCM |
$73.55 2.4% |
5 |
 |
Bruker BRKR |
$43.24 2.8% |
5 |
 |
Treace Medical Concepts TMCI |
$8.5 2.2% |
6 |
News
PODD Alternative Data
Web Traffic
Insulet receives an estimated 103256 monthly visitors to insulet.com.
-
Web Traffic
103256
-
Change from Previous Month
16.9%
-
3 Month Change
4%
-
YoY Change
4%
News Mentions
Insulet was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
83.3%
-
3 Month Change
0%
Reddit Mentions
Insulet has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Insulet has 7,979 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
7979
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Facebook Engagement
Insulet has engaged 844 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
844
-
Daily Change
0%
-
1 Month Change
27.9%
-
3 Month Change
91.1%
-
YoY Change
91.1%
Instagram Followers
Insulet has 57,483 Instagram Followers on its main Instagram account, up by 0.9% over the last month.
-
Instagram Followers
57483
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.9%
-
YoY Change
2.9%
LinkedIn Followers
98,789 are following Insulet on LinkedIn, up by 4.6% over the last month.
-
LinkedIn Followers
98789
-
Daily Change
0.1%
-
1 Month Change
4.6%
-
3 Month Change
14.4%
Job Postings
Insulet has an estimated 214 open job postings, which is down -26% over the last month.
-
Job Postings
214
-
Daily Change
19.9%
-
1 Month Change
26%
-
3 Month Change
27%
-
YoY Change
27%
LinkedIn Employees
According to LinkedIn, Insulet has 3,836 employees, up by 1.5% over the last month.
-
LinkedIn Employees
3836
-
Daily Change
0%
-
1 Month Change
1.5%
-
3 Month Change
7.1%
-
YoY Change
7.1%
Business Outlook
According to employee reviews, the business outlook among employees at Insulet is 85 out of 100 (very bullish).
-
Business Outlook
85
-
Change from Previous Month
1.2%
-
3 Month Change
0%
-
YoY Change
0%
PODD Financials
PODD Key Metrics
-
Total Revenue
$597.5M
-
Net Income
$100.7M
-
Earnings per Share
$1.54
-
Free cash flow
$91.7M
-
EBITDA
$141.5M
-
EBITDA Ratio
0.23682
-
Total Assets
$3.1B
PODD 2-year Revenue & Income
PODD 2-year Free Cash Flow
PODD Technicals
PODD SMA
PODD RSI
FAQ
What's the current price of Insulet (PODD) Stock?
The price of an Insulet (PODD) share is $272.7.
What's the market cap of Insulet?
The current market cap of Insulet is 19.2B.
Should I buy or sell PODD?
Insulet shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Insulet is better viewed as a hold or accumulate position while waiting for further developments.
Is Insulet a good investment?
The current analysis of Insulet's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Insulet's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Insulet (PODD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Insulet stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Insulet (PODD) that investors often compare it to?
Insulet (PODD) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.
What is the forecast for Insulet's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Insulet's stock price to be around $282.3 in 2026. Starting from the current price of $272.7, this represents a 3.5% change in price, indicating a neutral outlook for the stock.
How to buy Insulet (PODD) Stock?
Insulet stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Insulet shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.